Herbert Virgin Vir Biotechnology, Inc. (VIR) insider trading activity

Herbert Virgin is EVP, Research & CSO of Vir Biotechnology, Inc.. Currently has a direct ownership of 262,500 shares of VIR, which is worth approximately $2.1 Million. The most recent transaction as insider was on Aug 09, 2022, when has been sold 78,093 shares (Common Stock) at a price of $5.96 per share, resulting in proceeds of $465,434. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 263K

0% 3M change

0% 12M change

Total Value Held $2.1 Million

Herbert Virgin Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 09 2022	BUY Exercise of conversion of derivative security	$465,434 $5.96 p/Share	78,093 Added 22.93%	262,500 Common Stock
Mar 10 2022	BUY Exercise of conversion of derivative security	$13,770 $1.53 p/Share	9,000 Added 4.65%	184,407 Common Stock
Feb 22 2022	SELL Open market or private sale	$41,250 $30.0 p/Share	1,375 Reduced 0.78%	175,407 Common Stock
Feb 22 2022	BUY Grant, award, or other acquisition	-	70,000 Added 28.52%	175,407 Common Stock
Feb 22 2022	BUY Exercise of conversion of derivative security	$2,104 $1.53 p/Share	1,375 Added 0.77%	176,782 Common Stock
Feb 17 2022	SELL Open market or private sale	$73,215 $31.93 p/Share	2,293 Reduced 2.13%	105,407 Common Stock
Feb 08 2022	SELL Open market or private sale	$46,667 $33.94 p/Share	1,375 Reduced 1.26%	107,700 Common Stock
Feb 08 2022	BUY Exercise of conversion of derivative security	$2,104 $1.53 p/Share	1,375 Added 1.24%	109,075 Common Stock
Jan 25 2022	SELL Open market or private sale	$44,632 $32.46 p/Share	1,375 Reduced 1.26%	107,700 Common Stock
Jan 25 2022	BUY Exercise of conversion of derivative security	$2,104 $1.53 p/Share	1,375 Added 1.24%	109,075 Common Stock
Jan 11 2022	SELL Open market or private sale	$48,262 $35.1 p/Share	1,375 Reduced 1.26%	107,700 Common Stock
Jan 11 2022	BUY Exercise of conversion of derivative security	$2,104 $1.53 p/Share	1,375 Added 1.24%	109,075 Common Stock
Dec 28 2021	SELL Open market or private sale	$54,931 $39.95 p/Share	1,375 Reduced 1.26%	107,700 Common Stock
Dec 28 2021	BUY Exercise of conversion of derivative security	$2,104 $1.53 p/Share	1,375 Added 1.24%	109,075 Common Stock
Dec 15 2021	SELL Open market or private sale	$137,500 $50.0 p/Share	2,750 Reduced 2.49%	107,700 Common Stock
Dec 15 2021	BUY Exercise of conversion of derivative security	$4,207 $1.53 p/Share	2,750 Added 2.43%	110,450 Common Stock
Dec 14 2021	SELL Open market or private sale	$63,085 $45.88 p/Share	1,375 Reduced 1.26%	107,700 Common Stock
Dec 14 2021	BUY Exercise of conversion of derivative security	$2,104 $1.53 p/Share	1,375 Added 1.24%	109,075 Common Stock
Nov 30 2021	SELL Open market or private sale	$722,975 $47.8 p/Share	15,125 Reduced 12.31%	107,700 Common Stock
Nov 30 2021	BUY Exercise of conversion of derivative security	$23,141 $1.53 p/Share	15,125 Added 10.96%	122,825 Common Stock
Nov 16 2021	SELL Open market or private sale	$44,921 $32.67 p/Share	1,375 Reduced 1.26%	107,700 Common Stock
Nov 16 2021	BUY Exercise of conversion of derivative security	$2,104 $1.53 p/Share	1,375 Added 1.24%	109,075 Common Stock
Nov 02 2021	SELL Open market or private sale	$50,792 $36.94 p/Share	1,375 Reduced 1.26%	107,700 Common Stock
Nov 02 2021	BUY Exercise of conversion of derivative security	$2,104 $1.53 p/Share	1,375 Added 1.24%	109,075 Common Stock
Oct 19 2021	SELL Open market or private sale	$53,446 $38.87 p/Share	1,375 Reduced 1.26%	107,700 Common Stock

Herbert Virgin

EVP, Research & CSO

San Francisco, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VIR shares.

Notify only if

Value

Insider Trading

Get notified when an Vir Biotechnology, Inc. insider buys or sells VIR shares.

Notify only if

Operation

Value

Type

News

Receive news related to Vir Biotechnology, Inc.

Track Activities on VIR

Account